EN
HI
Summary
As of 30 Oct, 2026, Marksans Pharma stock price is ₹315.35. During the trading session, the stock has moved between an intraday low of ₹300.00 and an intraday high of ₹318.80. Over the last 52 weeks, Marksans Pharma has traded between ₹155.00 and ₹350.95.
The stock has recorded a trading volume of 20,08,915 shares,. Its Average Traded Price (ATP) is ₹313.50, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 53 @ ₹315.35.
Marksans Pharma has an upper circuit limit of ₹366.20 and a lower circuit limit of ₹244.20. The total value traded stands at ₹62.98 CR, and the delivery percentage for the day is 47.96%.
The stock is currently traded with a market lot size of 1. Marksans Pharma also offers a dividend yield of 0.29%.
Marksans Pharma Share Price Chart
Marksans Pharma Share Key Metrics
Volume
20.09 L
Market Cap
14294.45 CR
LTQ@LTP
53@315.35
ATP
313.5
Var Margin
22.07 %
Circuit Range
244.2-366.2
Delivery %
47.96 %
Value
62.98 CR
ASM/GSM
No
Market Lot
1
Marksans Pharma Fundamentals
P/E Ratio
26.76
P/B Ratio
4.35
Div. Yield
0.29
Sector P/E
39.87
Sector P/B
3.27
Sec. Div. Yield
0.53
Marksans Pharma Resistance and Support
Pivot 304.03
Resistance
First Resistance
309.41
Second Resistance
313.63
Third Resistance
319.01
Support
First Support
299.81
Second Support
294.43
Third Support
290.21
Marksans Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 29 2026 | 305.9 | 315.35 | 3.33% | 318.8 | 300 |
| Wed Oct 28 2026 | 301.1 | 305.2 | 1.70% | 308.25 | 298.64 |
| Tue Oct 27 2026 | 297.6 | 300.1 | 1.17% | 303.1 | 294.79 |
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Quarterly Results |
| 2026-08-12 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Marksans Pharma News
Marksans Pharma Ltd - 524404 - Board Meeting Intimation for Declaration Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026
Marksans Pharma board will meet on 04 Nov 2026 to announce financial results for Q2 FY27. The meeting is scheduled to approve the quarter and half-year performance.
Oct 19 2026 15:47:14
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
Dr. Agarwal's Health Care Ltd.
488.70
13.55 (2.85%)
Poly Medicure Ltd.
1461.90
-14.10 (0.96%)
Vijaya Diagnostic Centre Ltd.
1464.20
21.40 (1.48%)
Molbio Diagnostics Ltd.
1302.60
-10.10 (0.77%)
Concord Biotech Ltd.
1230.60
-37.90 (2.99%)
CORONA Remedies Ltd.
2217.40
16.80 (0.76%)
Alivus Life Sciences Ltd.
1397.40
-2.00 (0.14%)
Rainbow Children's Medicare Ltd.
1196.80
-8.00 (0.66%)
Sudeep Pharma Ltd.
1130.10
11.10 (0.99%)
Metropolis Healthcare Ltd.
553.85
2.65 (0.48%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 315.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 26.76. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 4.35. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 39.87 & 3.27 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 14294.45 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 350.95 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MARKSANS
